TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · major macro event coming up
BIOA

BioAge Labs, Inc

Healthcare · Drug Manufacturers - Specialty & Generic · —

8.50$ +4.6% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Balance Sheet

BioAge Labs, Inc (BIOA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 397 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet BIOA
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
26 180 164 337 358 344 322 305 295 398 397
25 179 164 336 357 325 302 291 287 392 330
22 174 159 334 354 257 220 216 189 242 74
22 174 159 334 354 321 297 286 281 383 319
0.0 0.4 0.6 0.5 0.8 0.7 0.6
199 365 362 24 35 31 27 28 23 19 22
58 15 13 19 28 24 23 24 20 16 19
45 6.3 6.3 6.3 6.2 6.7 6.2 4.7 3.2 1.8 0.7
1.9 2.3 1.5 2.1 2.0 4.0 1.3 5.0 2.7 3.1 5.7
8.2 6.8 5.4 3.9 2.5 1.1
-173 -186 -197 314 323 313 295 277 272 379 375
-182 -195 -208 -232 -253 -266 -287 -307 -333 -356 -382
34 34 34 34 34 36 36 36 36 36 42 45

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?